Ward One of Obstetrics and Gynecology, The 2nd Affiliated Hospital of Harbin Medical University, Harbin, China.
Ward One of Gynecology Department, Harbin Medical University Cancer Hospital, Harbin, China.
Drug Dev Ind Pharm. 2020 Dec;46(12):1919-1926. doi: 10.1080/03639045.2020.1826508. Epub 2020 Oct 14.
Under the hydrothermal reaction condition, we prepared a new 3D Eu(III)-based coordination polymer (CP) [Eu(H-DHBDC)(DHBDC) (HO)] ·HO (, H-DHBDC = 2,5-dihydroxy-1,4-terephthalic acid). Furthermore, we assessed the inhibitory influence on cervical cancer cells of this compound. First, for testing the anti-viability of the compound against cervical cancer cells, the cell counting kit-8 (CCK-8) assay was carried out. Then, reactive oxygen species (ROS) detection kit was used to determine the ROS accumulation in the cervical cancer cells. Finally, after the Annexin V-FITC/PI apoptosis assay was finished, it was used for apoptotic cervical cancer cells after treated with compound. From the results of the software of pose scoring and molecular docking, we can see that the compound may bind to p91 by the functional side-chain of the ligand, which provided potential regulatory mechanisms for the compound.
在水热反应条件下,我们制备了一种新的 3D Eu(III) 配位聚合物(CP)[Eu(H-DHBDC)(DHBDC)(HO)]·HO(,H-DHBDC=2,5-二羟基-1,4-苯二甲酸)。此外,我们评估了该化合物对宫颈癌细胞的抑制作用。首先,为了测试化合物对宫颈癌细胞的抗活力,进行了细胞计数试剂盒-8(CCK-8)测定。然后,使用活性氧(ROS)检测试剂盒来确定宫颈癌细胞中 ROS 的积累。最后,完成 Annexin V-FITC/PI 凋亡测定后,用于测定化合物处理后的凋亡宫颈癌细胞。从构象评分和分子对接软件的结果可以看出,该化合物可能通过配体的功能侧链与 p91 结合,这为该化合物提供了潜在的调节机制。